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Abstract
Formation of a protected biofilm environment is recognized as one of the major causes of the increasing antibiotic
resistance development and emphasizes the need to develop alternative antibacterial strategies, like phage therapy. This
study investigates the in vitro degradation of single-species Pseudomonas putida biofilms, PpG1 and RD5PR2, by the novel
phage Q15, a ‘T7-like virus’ with a virion-associated exopolysaccharide (EPS) depolymerase. Phage Q15 forms plaques
surrounded by growing opaque halo zones, indicative for EPS degradation, on seven out of 53 P. putida strains. The absence
of haloes on infection resistant strains suggests that the EPS probably act as a primary bacterial receptor for phage infection.
Independent of bacterial strain or biofilm age, a time and dose dependent response of Q15-mediated biofilm degradation
was observed with generally a maximum biofilm degradation 8 h after addition of the higher phage doses (10
4 and 10
6 pfu)
and resistance development after 24 h. Biofilm age, an in vivo very variable parameter, reduced markedly phage-mediated
degradation of PpG1 biofilms, while degradation of RD5PR2 biofilms and Q15 amplification were unaffected. Killing of the
planktonic culture occurred in parallel with but was always more pronounced than biofilm degradation, accentuating the
need for evaluating phages for therapeutic purposes in biofilm conditions. EPS degrading activity of recombinantly
expressed viral tail spike was confirmed by capsule staining. These data suggests that the addition of high initial titers of
specifically selected phages with a proper EPS depolymerase are crucial criteria in the development of phage therapy.
Citation: Cornelissen A, Ceyssens P-J, T’Syen J, Van Praet H, Noben J-P, et al. (2011) The T7-Related Pseudomonas putida Phage Q15 Displays Virion-Associated
Biofilm Degradation Properties. PLoS ONE 6(4): e18597. doi:10.1371/journal.pone.0018597
Editor: Mark Alexander Webber, University of Birmingham, United Kingdom
Received December 23, 2010; Accepted March 5, 2011; Published April 19, 2011
Copyright:  2011 Cornelissen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was partially supported by the K.U. Leuven (STRT1/10/021TBA). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript. No additional external funding received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rob.lavigne@biw.kuleuven.be
Introduction
Biofilms are surface-associated complex bacterial communities
encased in a hydrated extracellular polymer matrix of exopoly-
saccharides (EPS), proteins, nucleic acids and lipids. They are
formed spontaneously on both inert and living systems in various
natural and man-made environments, from food processing to
industrial (e.g. water pipes) and hospital settings (e.g. burn wounds,
endocarditis and catheters). They represent an essential bacterial
survival strategy since biofilm-associated bacteria can reach a
thousand fold increased protection against antimicrobial agents
compared to their planktonic counterparts [1,2]. Very often the
antibiotic concentration to eradicate the biofilm is above the peak
serum concentration, rendering it ineffective in treating biofilm
infections [3]. As they also confer protection for host defense
mechanisms, biofilms are a leading cause of latent as wells as of
recurrent infections [4,5].
Pseudomonas putida belongs to the fluorescent group of the
Pseudomonas species, a group of opportunistic pathogens that
primarily cause nosocomial infections. In contrast to Pseudomonas
aeruginosa, the most prevalent pathogen, infections caused by
P. putida are rare and mostly reported in immunocompromised
patients, such as newborns [6], neutropenic and cancer patients
[7–9]. The ability to adhere to materials and to promote the
formation of biofilms appears the most important feature of the
pathogenicity of P. putida [10]. Despite a high susceptibility for
anti-pseudomonal b-lactams, multidrug-resistant P. putida isolates
to b-lactams, including carbapenems, have already been reported
[11–15].
The widespread emergence of resistance to antibiotics among
pathogenic bacteria emphasizes the need to explore new classes of
antibacterial agents, ones that cannot be resisted by the same
antibiotic resistant genes. (Bacterio)phage therapy (use of bacterial
viruses) may represent such a new class, with additional
advantages like self-replication at the site of infection and host
specificity, leaving the normal bacterial flora undisturbed [16]. To
penetrate EPS layers, some phages carry EPS depolymerases as
tail spikes or tail fibers, as part of the viral particle, to enable them
to reach the bacterial cell wall [17]. Consequently, phages cause
biofilm and capsule disruption by cell infection and lysis, as well as
by EPS degradation. The principle of EPS depolymerization as
biofilm destabilizing agent was first employed in the pre-antibiotic
era: potentially lethal pneumococcal infections in rabbits and
monkeys were controlled through administration of partially
purified depolymerase [18,19].
Despite biomedical and industrial interest for phages encoding
these enzymes, recent more in-depth research is limited and
mainly focused on the capsulated neuroinvasive Escherichia coli K1
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nad phages have been found in many of the environments in
which biofilms are formed, and despite the increasing volume of
studies on pseudomonad biofilms, only few groups have examined
the effect on biofilms of pseudomonad phages with associated EPS
depolymerases. Besides three historical references from Bartell and
colleagues [22–24], only two recent descriptive studies have been
published on the isolation of phages capable of degrading the
extracellular material elaborated by its P. putida or mucoid P.
aeruginosa hosts [25,26].
The present study investigates the in vitro biofilm degradation
capacity of a lytic P. putida phage Q15 with associated EPS
depolymerase on different aged single-species biofilms of two
P. putida strains, PpG1 and RD5PR2. In addition, we identified the
gene encoding for the EPS depolymerase within the sequenced
phage genome.
Materials and Methods
Phage, bacterial strains and media
Phage Q15 and P. putida strains (PpN, PpN3, PpN119, Pput
373, AC522, DSM9278 and PpG1) were isolated as described in
Shaburova et al. [25]. PpKT2440 and Pp00S82 were kindly
provided by Prof. D. Springael (Division Soil and Water
Management, K.U.Leuven, Belgium) and five other P. putida
strains (PSE072, PSE072B, PSE106, PSE107 and WGE060)
were obtained from Prof. M. Vaneechoutte (Laboratory
Bacteriology, Ghent University Hospital, Belgium). Prof. R.
De Mot (Centre of Microbial and Plant Genetics, K.U.Leuven,
Belgium) provided P. putida strains ATCC23287, GR12-2R3,
LMG2257 and a selection of 35 P. putida rice rizosphere strains
[27]. P. putida strains were grown in standard LB-medium at
30uC. Expression strain E. coli BL21(DE3) pLysS (Invitrogen
Corporation, Carlsbad, CA, USA) was grown at 30uCi n2 x T Y -
medium.
Phage purification
The CsCl ultracentrifugation method was performed as
described by Ceyssens et al. [28]. For purification and concentra-
tion by Convective Interactive Media (CIM), the diethylamine
(DEAE) CIMH disk monolithic column (12 mm63 mm i.d., bed
volume 0.34 ml; BIA Separations, Ljubljana, Slovenia) was used in
combination with the A ¨kta FPLC-system (GE Healthcare, Little
Chalfont, UK) and UNICORN
TM 5.01 software in a 20 mM Tris
buffer system at pH 7.5. The equilibration buffer with 1 M added
sodium chloride was used for elution. Shortly, an overnight culture
of a susceptible host strain was used to prepare a 2% inoculum,
which was incubated with shaking at 30uC. At OD600 nm of 0.45,
phage (10
6 pfu to a 50 ml culture) were added to the culture and
incubation continued until lysis was observed. The bacterial lysate
was subsequently centrifuged (3,0006 g, 30 min, 4uC), passed
through a 0.45 mm pore-size membrane filter (Millipore Corpo-
ration, Billerica, MA, USA) and adjusted (with HCl or NaOH) to
the pH of the buffer system. This cleared, filtered lysate was used
as the starting material for phage purification by CIM. In a
stepwise gradient profile (20, 30, 100% and 3 ml segment lengths)
to the Tris buffer containing 1 M NaCl, the major part of the
bound phage were eluted at 30% elution buffer. The DEAE disk,
with a capacity of ,8*10
10 pfu for phage Q15 can purify up to
,7*10
10 phage particles.
Microbiological characteristics
One-step growth curves of phage Q15 were made for two P.
putida strains, PpG1 and RD5PR2 [29]. In short, 5 min after
infection of a 1 ml P. putida culture (OD600 nm=0.45) at a start
pfu/CFU ratio of 0.008, the suspension was washed (1 min
centrifugation at 16.0606g, followed by resuspension of the pellet
in 1 ml LB, prewarmed at 30uC) twice and 10
24 and 10
25
dilutions were incubated at 30uC. Samples were taken at regular
intervals and titrated immediately using the double agar overlay
method. For the adsorption experiments [29], infection parame-
ters of the one-step growth experiments were maintained. At
1 min-time intervals, 100 ml samples were taken from the solution
and mixed with 850 ml LB-media and 50 ml CHCl3. After 10 min
of shaking, the supernatant is titrated to determine the number of
non-adsorbed or reversibly adsorbed phage.
The pH-stability of the phage was tested by incubating at room
temperature 10
8 pfu in 1 ml of a pH-buffer constituting of 10 mM
KH2PO4, 10 mM NaCitrate, 10 mM Boric Acid and 150 mM
KCl (pH-adjusted with NaOH or HCl to a pH within the pH-
range of 1 to 13). Each sample was titrated after a 24 h exposure
using the standard double agar overlay method [29], and
compared with control samples [10
8 pfu in a 1 ml standard phage
buffer (10 mM MgSO4, 150 mM NaCl, 10 mM Tris pH 7.5) also
incubated at room temperature for 24 h].
All phage-host combinations were evaluated by spot testing
10
7 pfu on a air-dried bacterial lawn (200 ml overnight culture
plated directly on LB agar plates) in three independent
experiments. After overnight incubation at 30uC, plates were
checked for the presence of a lysis zone against a negative,
uninfected control.
To visualize halo formation, 10 mlo fa1 0
8 pfu phage
suspension was dropped on a air-dried bacterial lawn (200 ml
overnight culture), plated on LB agar. Plates were sealed and
incubated at 30uC. For comparison of phage and bacterial count
in the three different zones (lysis, halo and bacterial zone), a
equally large surface was removed from each zone, suspended in
1 ml LB-medium and vortexed (30 s). Phage counts were
determined using the double agar method, while bacterial
numbers were counted after plating a dilution series of the
supernatant.
Development of phage resistant strains and UV
inactivation of phage particles
200 ml of a bacterial overnight culture was plated on a petri
dish with solid LB medium. After drying, 10 mlo f1 0
8 pfu/ml of a
Q15 phage suspension was dropped on this plate, which was
sealed after drying and incubated at 30uC until colonies became
visible in the lysis zone. Colonies were picked and subjected to
single-colony isolation three times. The double agar overlay
method was used to verify resistance to phage Q15 of the different
selected colonies.
The UV oven (Bio-Link, Vilber Lourmat, France) was equipped
with five fluorescent lamps of 8 W each, emitting 180 to 280 nm
with a peak at 254 nm. The distance between the lamps and the
plates was 14 cm. The UV doses were programmed and
controlled by a radiometer which constantly monitors the UV
light emission. To inactivate phage particles by UV illumination,
25 ml of phage (10
11 pfu/ml) was dropped on an empty petri dish
and irradiated in the UV oven (1 kJ/m
2).
Capsule staining
Bacterial cells, scraped from a fully grown agar plate, were
transferred to a 10 ml drop of 1% aqueous Congo red solution
(Sigma-Aldrich, St. Louis, MO, USA). This suspension was spread
across a microscopic glass slide to form a thin film, which was air-
dried. A 10 ml drop of Maneval’s solution [3.33% fenol, 4.44%
glacial acetic acid, 2.67% ferric chloride, 0.02% acid fuchsin
Phage Q15 Degrades Pseudomonas putida Biofilms
PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e18597(Sigma-Aldrich)], distributed across the slide, acidifies the Congo
red background into blue [30] and colors cells red. Capsules are
not stained and appear white underneath the light-microscope
(1006, oil; Leica DM LB microscope; Mc Bain instruments, Simi
Valley, CA, USA).
Biofilm assay
The device used for biofilm formation is a platform of 96
polystyrene pegs (Nunc-Immuno TSP, Thermo Fischer Scientific,
Tournai, Belgium) that fits as a microtiter plate lid with a peg
hanging in each microtiter plate well (Thermo Fischer Scientific)
[31]. Overnight cultures were diluted 1/200 in LB-medium in the
96 wells of the microtiter plate. After hanging the pegs in the
wells, the microtiter plate was sealed to avoid water loss due to
evaporation. Biofilms were allowed to grow for different periods
of times at 30uC without shaking. For biofilm growth assays
longer than 24 h, media were renewed every 24 h by placing the
pegs in a new microtiter plate containing media. For quantitative
biofilm analysis, the pegs were washed once in 200 mlL B -
medium. The remaining attached bacteria were stained with
200 ml 0.1% (w/v) crystal violet (Merck) in an isopropanol-
methanol-PBS solution [1:1:18 (v/v)] for 30 min, washed with
LB-medium to remove excess stain and air-dried (30 min).
Afterwards, the dye bound to the adhered cells was extracted
in 200 ml 30% glacial acetic acid. The intensity of the eluted dye
in each well was measured at OD600 nm with the Multiskan RC
(Thermo Labsystems, Finland). The planktonic survival was
determined simultaneously by an optical density measurement
(600 nm; Multiskan RC) of 135 ml supernatant removed from the
microtiter plate in which the pegs were hanging. Differences in
biofilm and planktonic survival compared to the untreated
control samples were analyzed using the two-tailed t test, P-
values of ,0.01 were considered significant.
Cloning, recombinant expression and purification
Purified genomic Q15 DNA served as template for amplifica-
tion of gene 17 using Pfu DNA polymerase (Fermentas Life
Science) and the specific primer pair (59-ATGGCACGAAC-
TATCGTC-39 and 59-CTACCCGACCAGCTCGATCAG-39;
Eurogentec, Seraing, Belgium). The PCR product was cloned in
the pEXP5-NT/TOPOH TA expression vector (Invitrogen
Corporation) according to the manufacturer’s protocol in order
to obtain a 6xHis-tag fusion protein for purification. The
construct was verified by DNA sequencing using vector-specific
primers (59-TAATACGACTCACTATAGGG-39 and 59-TAGT-
TATTGCTCAGCGGTGG-39, Eurogentec) and an internal
primer (59-ACGTGGTGTCATCAAC-39, Eurogentec). Expres-
sion occurred at 37uC for 4 h in E. coli BL21(DE3)pLysS
(Invitrogen Corporation) after induction with 0.1 mM isopropyl-
b-D-thiogalactopyranoside of 0.5 L exponentially growing cells
(OD600 nm=0.6) in 2xTY medium. Protein purification was
essentially performed as described previously [32] with a
HisTrap
TM HP 1 ml column (Amersham Biosciences) in
combination with an A ¨kta FPLC-system (GE Healthcare) and
UNICORN
TM 5.01 software. Wash and elution buffers were
composed of 20 mM NaH2PO4 pH 8.5, 0.5 M NaCl and 10%
glycerol with 75 mM and 0.5 M imidazole, respectively. Protein
purity was at least 95% as estimated by SDS-PAGE. Purified
protein was dialyzed overnight against a volume of PBS buffer
(137 mM NaCl, 2.7 mM KCl, 10 mM NaHPO4,2 m M
KH2PO4 pH 7.4) that was 10006 the volume of the protein
sample using Slide-A-LyzerH MINI Dialysis units (Pierce
Biotechnology, Rockford, IL, USA).
Results
Microbiological characteristics
Bacteriophage Q15 propagates on P. putida strain PpG1 and
infects six other strains (PpN, PpN3, RD6PR1, RD5PR2,
RD8PR2 and RD8PR3) from a diverse collection of 53 P. putida
strains. These seven P. putida strains show very diverse biofilm
forming capacities, ranging from a very weak to a moderate
biofilm formation (Figure S1). None of the phage-sensitive strains
forms thick biofilms.
Transmission electron microscopic imaging revealed Q15 as a
typical short tailed member of the Podoviridae family of double-
stranded DNA bacteriophages (58.9 nm head; 1268 nm tails)
(Figure S2). Phage Q15 is stable in a relatively narrow pH range (5
to 11) (Figure S3A). The phage exhibits a very efficient infection
cycle on its host PpG1: 95.2% of Q15 phage particles are
irreversible adsorbed (k=2.51*10
28) within the first minute after
infection of a bacterial culture (Figure S3B). PpG1 host cells are
lysed after 21 min, releasing an average of 95 newly formed phage
particles per cell (Figure S3C). However, under the same
laboratory conditions, Q15 exhibited a remarkably lower adsorp-
tion to strain RD5PR2 (17.38% adsorbed phage particles after
1 min; k=2.23*10
29) (Figure S3B). As a consequence, lysis of
RD5PR2 cells occurred unsynchronized, which was observed by a
gradual release of phage particles starting 90 min post infection
(Figure S3D).
The large (5-mm diameter) and clear plaque morphology of Q15
hints a strictly lytic nature. The most distinct plaque feature is the
opaque halo zone with an increasing diameter over the course of
time, surrounding a plaque with constant diameter (Figure 1).
When 10
8 pfu of phage were dropped on a lawn of host bacteria,
the lysis zone caused by infection and subsequent lysis of host cells,
kept a constant diameter with prolonged incubation. The halo
zone increased up to 3 mm in diameter every 24 h and eventually
spread across the whole petri dish. An opaque halo zone
surrounding the plaque was observed for each of the seven strains
(PpG1, PpN, PpN3, RD6PR1, RD5PR2, RD8PR2, RD8PR3) out
of the collection of 53 P. putida strains sensitive for Q15 infection. A
halo zone was not observed when phage were dropped on a
bacterial lawn resistant to infection, coupling phage sensitivity and
halo formation. Phage enumeration of equally large surfaces of the
lysis, halo and bacterial zones outside the halo revealed that only a
tenfold less phage were found in the halo zone (1.6*10
6 pfu)
compared to the lysis zone (1.9*10
7 pfu), while phage were
completely absent in the outside bacterial zone. A bacterial count
of the same samples indicated the absence of viable bacterial cells
within the lysis zone, except for the one or two resistant colonies.
The halo and the outside bacterial zone harbored an almost equal
amount of viable cells (4.56*10
7 and 4.43*10
7 CFU, respectively).
Phage-mediated biofilm degradation
Phage-mediated biofilm degradation was evaluated for phage
Q15 on 24 h and 48 h old single-species biofilms of two P. putida
strains PpG1 and RD5PR2, grown under static conditions at
30uC. Infection parameters were varied to determine the most
optimal biofilm degradation conditions: time periods for phage
infection ranged from 2 to 24 h and the applied phage titers were
10
2,1 0
4 and 10
6 pfu/well.
Biofilm degradation of PpG1 biofilms. A time and dose
dependent biofilm degradation is observed for Q15 infection of
PpG1 biofilms initially grown for 24 h. A maximal biofilm
reduction was reached 8 h after each phage dose was added (e.g.
96% for initially 10
6 pfu added) (Figure 2A). The planktonic
survival decreased in parallel, but more rapidly than the biofilm
Phage Q15 Degrades Pseudomonas putida Biofilms
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18597Figure 1. Plaques of P. putida phage Q15 on the host PpG1. With increasing time of incubation the diameter of the halo zone, surrounding the
plaque with constant diameter, increases up to 3 mm every 24 h.
doi:10.1371/journal.pone.0018597.g001
Figure 2. Phage Q15-mediated biofilm degradation. 24 h (A) and 48 h (B) old biofilm of PpG1. 24 h (C) and 48 h (D) old biofilm of RD5PR2.
Biofilms grown on cones for 24 or 48 h, were initially inoculated with 10
2,1 0
4 and 10
6 pfu of phage Q15. After 2, 4, 8 and 24 h of phage treatment at
30uC, mean biofilm (BT: biofilm treatment) and planktonic survival (PCT: planktonic culture treatment) for n=20 cones or corresponding microtiter
plate wells, respectively, were scored relative to untreated control samples (100%) and represented on the Y-axes. Five independent experiments
were performed, each starting from a different overnight culture and each with four repeats for each parameter combination giving rise to an overall
twentyfold repetition. Error bars indicate SEM. Significant values (two-tailed t test; P,0.01) are marked by a asterisk (*).
doi:10.1371/journal.pone.0018597.g002
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survival decreased to 32 and 11% for 10
4 and 10
6 pfu of Q15,
respectively. The maximum of planktonic decrease was reached
already 4 h after addition of the higher phage doses (10
4 and
10
6 pfu) and after 8 h for initially 10
2 phage particles added.
Despite this dose and time responsive behavior, phage counts
within the planktonic culture rapidly attained the steady state
level of about 7.5 log10 for every initial phage titer added
(Figure 3A). Even for only a hundred phage particles added, the
maximum phage count (67.5 log10) was already reached after
4 h, at which point also a sharp decrease in planktonic survival
(from 128 to 42%) was observed. Surprisingly, biofilm degrada-
tion lagged at least 2 h behind, as a sharp increase in biofilm
degradation was only observed between 4 and 8 h (11 to 69%)
after initial infection. Similar observations were made for higher
initial phage titers: the plateau level of phage count was already
reached after 2 h at which point the biofilm degradation was still
limited to 611%. A possible explanation is that free living
planktonic cells are easier accessible for phage infection than cells
associated within and protected by a biofilm environment. Cells
within a biofilm environment are also much less metabolic active,
hereby slowing down the infection process, and coupled biofilm
destruction.
Although also being time and dose dependent, at every time
point the measured biofilm degradation and planktonic killing of
the 48 h old biofilm were much lower than for the 24 h old biofilm
(Figure 2A+B). Like for the 24 h old biofilm, a maximal
degradation was reached for the higher phage doses after 8 h,
but only 38 and 55% of the biofilm was degraded compared to 87
and 96% for the 24 h old biofilm after initial inoculation with 10
4
and 10
6 phage, respectively. When the 48 h grown biofilm was
inoculated with only 10
2 pfu of Q15, no significant biofilm
degradation was observed during the 24 h incubation period, in
contrast with a maximal biofilm degradation of 69% reached after
8 h for the 24 h old biofilm. In parallel, we noticed higher
planktonic survival rates for 48 h old biofilms: as these older
biofilms slowly decay, biofilm-freed cells hereby continuously
enrich the planktonic culture. Nevertheless, phage amplification
occurred as rapidly as observed for the 24 h old biofilm, reaching
steady-state values of about 7.5 log10 at the earlier time points for
every initial phage titer applied (Figure 3A+B). A gradual biofilm
and planktonic regrowth was observed 24 h after phage exposure
for the different phage inoculation titers (except for 10
6 phage
added to the 24 h old biofilm) for both the 24 h and 48 h
pregrown biofilm implying bacterial resistance development
against phage infection.
Figure 3. Phage amplification. 24 h (A) and 48 h (B) old biofilm of PpG1. 24 h (C) and 48 h (D) old biofilm of RD5PR2. Biofilms grown on cones for
24 or 48 h, were initially inoculated with 10
2,1 0
4 and 10
6 pfu of phage Q15. After 2, 4, 8 and 24 h of phage treatment with 10
2,1 0
4 and 10
6 pfu of
phage Q15 at 30uC, mean phage counts recovered from liquid media in n=4 microtiter plate wells [log10(phage titer)] were scored. Error bars indicate
SEM.
doi:10.1371/journal.pone.0018597.g003
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strains. Although PpG1 (0.69) forms thicker biofilms than
RD5PR2 (0.54), 24 h old RD5PR2 biofilms are less susceptible for
biofilm degradation than PpG1 (Figure 2A+C). Only 8 h after
addition of at least 10
4 phage, a first significant degradation was
seen. Almost identical observations were made for the 48 h old
biofilm of RD5PR2 as for the 24 h old (Figure 2C+D), indicating
no difference in biofilm susceptibility between different aged
biofilms of this strain.
In contrast to this lower biofilm susceptibility, RD5PR2
planktonic cultures were rapidly lysed in the presence of 10
4 and
10
6 pfu of Q15. However, the addition of the lowest titer (10
2 pfu)
to the 24 old biofilm did only induce a minor decrease in
planktonic survival (maximum of 13% for RD5PR2 compared
with 92% for PpG1). Also, no losses were noted in susceptibility of
the RD5PR2 planktonic cultures with increasing biofilm age
(Figure 2C+D).
24 h after phage inoculation, we observed for both RD5PR2
biofilms a drastic increase in biofilm and planktonic growth:
biofilms grew thicker than the wildtype (.100%) and planktonic
cultures were regrown to about 80% of the wildtype. As a
regrowth is indicative for the development of phage resistant
bacteria, this is in sharp contrast with the further increasing phage
count (Figure 3C+D). An inefficient adsorption and release of
phage particles during RD5PR2 infection can probably explain
the further increasing phage titer at a moment of pronounced
resistance development.
Identification of the Q15 tail spike protein by genome
analysis
Genome sequencing of Q15 revealed a typical T7-like genome,
comprising 39,562 bp and bracketed by 264 bp direct terminal
repeats. The genome contains 50 predicted ORFs, all orientated in
the same direction and leaving only 6.3% of the genome
noncoding. It can be functionally divided into three regions
involved in (i) host conversion, (ii) nucleotide metabolism and
DNA replication, and (iii) morphogenesis and host cell lysis (Figure
S4 and Table S1). With a overall G+C average of 58.2%, the
highest of all ‘T7-like viruses’, Q15 approaches the high G+C
content (61%) of its host. No tRNA genes were predicted, as
expected for a member of the ‘T7-like viruses’.
The entire Q15 genome has 55.5% overall DNA similarity to its
closest T7-homolog, the P. putida phage gh-1 [33] and shares 34
out of 50 Q15 ORFs with this phage. While 28 ORFs are typical
for ‘T7-like viruses’, six ORFs are unique to Q15 and gh-1 and
probably result from adaptation to the P. putida host. Five of these
genes are encoded in the DNA replication region, while the
particle structure genes are highly conserved. Fifteen other ORFs
(except Q15/16), unique for Q15 and located in the early and
middle region, probably represent a further adaptation to a
particular group of P. putida strains. Using ESI-MS/MS analysis
on purified and denatured phage particles, fourteen structural
phage proteins were identified (Table S2). This analysis delineated
the structural region from 6.7 to 17 and identified also two early
and two middle gene products as being part of the structural phage
particle. A detailed discussion of the Q15 genome is provided in the
supplementary data (Text S1, Table S3, Table S4, Figure S5).
Based on the genome sequence, a T7-like infection cycle can be
predicted for Q15.
Tail spike protein
For most ‘T7-like viruses’ (T3, T7, QA1122, QYeO3-12 and gh-
1), the viral tail spike (Gp17) recognizes and adsorbs to specific
sugars of the host lipopolysaccharide (LPS) [34,35]. For example,
QYeO3-12 is specific for the O3 antigen of Yersinia enterocolitica,T 3
binds to glucose residues in the outer core of rough E. coli strains,
while T7 binds to more inner moieties. In contrast, E. coli K1
phage K1F encodes a tail-associated endosialidase which recog-
nizes and depolymerizes the K1 polysialic acid capsule instead of
LPS structures [36]. Within the classified ‘T7-like viruses’, a
conserved N-terminal head-binding domain is present, which is
reasonably similar in length (6149 AA) and necessary for
association with the tail structure (Figure 4) [37]. Gp17 of Q15
(728 AA) shares a 49.7% amino-acid identity in this N-terminal
region with gh-1, while the C-terminal two-third of the tail spike is
only 18.3% homologous. Also for other members of the ‘T7-like
viruses’, these C-termini differ markedly in amino-acid sequence
and length. They form the distal part of the tail spike protein and
are involved in recognition of and binding to the host cell receptor.
It was expected that the Q15 tail spike (Gp17) serves EPS
degrading activity. However, homology on the level of the primary
amino-acid sequence (BlastP) is limited to the conserved N-
terminal domain of the ‘T7-like viruses’. Further analysis of Gp17
of Q15 using Phyre [38] indicated that there is a significant chance
(75%) that Gp17 of Q15 has right-handed b-helical folds, similar to
pectin lyases (E-value 0.77). These right-handed b-helical
structural elements were so far only identified in carbohydrate
binding (and depolymerizing) enzymes of microbial or viral origin
and in an autotransporter family of secreted bacterial proteins
[39]. Large-scale recombinant expression of the 80 kDa Q15 tail
spike protein allowed purification of low yet pure amounts of this
protein. Dropping 10 ml of this solution in parallel with a 10
8 pfu
phage suspension on a bacterial PpG1 lawn confirmed the
presence of the EPS degrading activity within the tail spike
protein of Q15, as the recombinantly purified tail spikes formed
identical looking opaque halo zones as those found around the
lytic zone caused by phage infection. Further microscopical
analysis of these halo zones and the outside bacterial zone clearly
shows that the EPS material keeps bacteria closely associated
within small cell clusters. In contrast, virtually all bacteria within
the halo zone are separated from each other, their EPS material is
reduced and sometimes completely removed (Figure 5).
Role of the viral tail spike in biofilm degradation
To differentiate between the individual contributions of Q15 in
bacterial cell lysis and EPS depolymerization to biofilm degrada-
tion, we attempted to isolate PpG1 strains which are resistant to
phage infection, but susceptible for halo formation. However, all of
twelve infection resistant strains were also resistant for halo
formation. This observation indicates that, although resistance
development can occur through various mechanisms (deletion or
mutation of receptor sites, host DNases, …), modification or loss of
the EPS receptor must be the most straightforward. This again
suggest that the EPS receptor is probably a primary and essential
receptor for Q15 infection, as supported by the specific host range
of the phage.
In a last step, phage Q15 particles were inactivated by UV
radiation mutagenesis, which rendered the particle non-infective
but left the enzymatic activity of viral tail spike proteins unharmed.
When these particles were dropped onto a bacterial lawn, an
opaque halo zone appeared after overnight incubation at 30uC.
Further capsule staining of bacteria isolated from these halo zones
confirmed the individual arrangement of cells within these zones.
Finally, addition of UV inactivated particles (10
2,1 0
4 and 10
6 pfu)
to 24 h old PpG1 and RD5PR2 biofilms did not influence the
pregrown biofilm at the different time points measured after
inoculation (2, 4, 8 and 24 h; data not shown).
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The aim of this study was to investigate the in vitro biofilm
degradation capacity of the lytic P. putida phage Q15, a ‘T7-like
virus’ with an EPS depolymerase associated with its tail. Our
results suggest that EPS material serves as a primary bacterial
receptor for phage adsorption, and that specific adsorption to and
disruption of this receptor is necessary to accomplish the phage
replication cycle. This was also observed for phages infecting the
capsulated Vibrio cholera O139 strain [40], Escherichia coli K95 [41]
and K1 strains [42] and two Enterobacter agglomerans strains [43].
A central observation in this study were the characteristic
expanding opaque halo zones, which surrounded all Q15 plaques.
Sixty years ago, these halo zones were already described as an
indicator for the presence of phage-associated EPS depolymerases
[44]. The observed presence of both phage and viable bacteria in
these halo zones can be explained by the need for actively dividing
cells for phage replication. When the bacterial population enters
the stationary phase of growth, phage replication often ceases or
slows down substantially but their tail spikes are still capable of
depolymerizing bacterial EPS creating a zone of increased
transparency, the halo zone. This zone will increase in diameter
over time, as phage diffuse out of the lysis zone of primarily
infected bacteria. Based on this observation, one can hypothesize
that halo formation is not only caused by the excess of EPS
depolymerases produced inside the host during phage replication
and released upon bacterial lysis as proposed previously [25,45–
47], but also by viral diffusion out of the lysis zone. In that case,
differences in halo sizes between different phages are not only
dependent on the amount of free enzymatic active spikes [45–47],
but also on the number of phage produced in one single plaque,
which is dependent on the burst size, latent period and adsorption
efficiency of that specific phage.
When studying the interaction between phage and biofilm-
embedded bacteria, we noticed a time and dose dependent
response for Q15-mediated biofilm degradation for 24 h and 48 h
old biofilms of PpG1 and RD5PR2, with maximal biofilm
degradation 8 h after the higher phage doses (10
4 and 10
6) were
Figure 4. ClustalW alignment of the conserved N-terminal domain of the tail spike proteins (Gp17) of all classified ‘T7-like viruses’.
Identical residues are marked in black and similar residues are shaded in two different gray scales, the darker gray marking the higher chemical and
physical similarity. Numbering starts at the N-terminal methionine. Gaps, indicated by horizontal lines, were introduced into the sequences to
maximize the alignment.
doi:10.1371/journal.pone.0018597.g004
Figure 5. Capsule staining of bacteria in the outside bacterial (A) and in the halo (B) zone. Within the outside bacterial zone bacteria are
all encircled by white capsule and packed closely together, while in the halo zone bacteria are lying separately and have sometimes lost their white
capsule.
doi:10.1371/journal.pone.0018597.g005
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2 phage when added to the 24 h old
biofilm of the highly susceptible PpG1 strain). Similar observations
were made in E. coli biofilms, exposed to different doses of phage
T4, a phage without any EPS depolymerases [48] and to both
wild-type phage T7 and its engineered derivative T7DspB, which is
responsible for an intracellular expression of biofilm-degrading
enzymes during its infection [49]. Likewise, a time responsive
relative biomass removal was observed for all different aged
Pseudomonas fluorescens biofilms (up to 168 h) subjected to initial
10
7 pfu of phage QIBB-PF7A [50]. Based on these observations,
we can deduce that independent of the presence or absence of EPS
depolymerases, time and dose responsive behavior of phage-
mediated biofilm disruption seems a common characteristic and
this biofilm degradation can probably be increased upon the
presence of EPS depolymerase enzymes. Moreover, the maximal
biofilm degradation is even dose dependent in the presence of very
efficiently replicating phage [e.g. the maximal attained phage titer
(67.5 log10) for the PpG1 biofilms was reached only 2 h after
phage inoculation for all applied titers], with higher initial phage
titers ensuring a greater maximal biofilm destruction.
Another important and in vivo very variable parameter is the age
of the pregrown biofilm. An older biofilm is usually thicker (e.g.
48 h old PpG1 biofilms are about 2.5 times thicker than 24 h old
biofilms), which makes biofilm degradation more difficult.
However, as a biofilm ages, also different phenotypic variants
(which can become phage resistant due to loss or change of outer
membrane receptors, hereby causing phages to become ‘trapped’
in the biofilm layers) develop within the biofilm layers [51] and
due to diffusion constraints of oxygen and nutrients, cells in the
lower part of the biofilm become less metabolic active [52,53].
These two factors may lead to reduced phage susceptibility,
depending on the location within the biofilm. Within this study, we
noted a marked decrease in phage susceptibility of the PpG1
biofilm with increasing age, while RD5PR2 biofilms retained their
susceptibility. Age also influenced the susceptibility of P. fluorescens
biofilms subjected to phage QIBB-PF7A, with the older biofilms
(120 and 168 h) being the least susceptible [50]. Similar to our
RD5PR2 observations, Hanlon et al. [54] did not report a
significant decrease in susceptibility of P. aeruginosa biofilms to
phage F116 with age, as F116 was also very effective against 20-
day-old biofilms. In all medical, food and industrial environments,
where phage therapy would find its application, it is of great
importance that phages are capable of degrading biofilms of
different ages. As observed in this work, maintenance of high
phage susceptibility over a wide age range of biofilms formed by
one host, does not ensure the same results for another host exposed
to that same phage. In contrast to biofilm degradation, Q15
amplification was not influenced by the age of the preformed P.
putida biofilms, which was also observed by Sillankorva et al. [50].
Probably, this increase in phage numbers is predominantly due to
amplification in the planktonic culture which is in equilibrium with
the biofilm. The physiological state of these cells is rather similar
independent of the age of the biofilm. This also explains that the
decrease in planktonic survival occurred rather in parallel with the
phage amplification, although the extent at which this occurred
was still influenced by the phage-susceptibility of the biofilm.
From these results, it is clear that the extrapolation of phage-
planktonic susceptibility for evaluation of phages for therapeutic
purposes would be misleading, as observed with the high
planktonic, yet low biofilm susceptibility of strain RD5PR2 for
phage Q15. One can hypothesize that the resistance of the
RD5PR2 biofilm for phage infection and subsequent degradation
in comparison with the high planktonic susceptibility can be
explained by diffusion constraints within the biofilm. Q15 forms a
haloed plaque with infection of PpG1 and RD5PR2 strains
indicating that the viral tail spike can break down the EPS
produced by both strains. Hypothetically, a reduced activity of the
viral EPS depolymerase on the RD5PR2 EPS material and/or
different exopolymer composition with a higher DNA or protein
content to EPS could strengthen the RD5PR2 biofilm compared
to PpG1, hereby leading to a hampered flow through of phage and
consequently a reduced RD5PR2 biofilm degradation. This could
be tested for by measuring the diffusion of phage through the
biofilm. An additional explanation lies in the phage amplification
characteristics (adsorption, latent period and burst size). Phage
Q15 shows poor adsorption (k1m i n=2.23*10
29) on RD5PR2 and
an inefficient infection cycle with a occasional release of phage
particles starting 90 min post infection but without a defined burst
size or latent period, while having a very efficient infection cycle
on PpG1. Consistent with this observation, phage amplification on
the RD5PR2 biofilms occurred with a constant increase in phage
count with prolonged incubation period, reaching its maximum
count of about 7 log10 24 h after phage inoculation, whereas on
PpG1 a maximum was rapidly reached. This suggests that the
efficiency of the infection cycle on a specific host forms an
important criterion for phage selection. Carson et al. [55] came to
similar conclusions when using the same coli-proteus phage in
biofilm experiments: the 24 h old E. coli ATCC 11303 biofilm was
reduced by three-log titers, while a Proteus mirabilis biofilm
diminished by only an approximate one-log.
One of the main concerns with regard to phage therapy is the
development of phage resistance. Contrary to some papers which
reported increasing phage-mediated biofilm destruction for
incubation periods longer 24 h [49,55], we clearly observed an
increase in biofilm and planktonic survival after 24 h for every
initial phage titer added. This was probably caused by bacterial
resistance development against phage infection as was previously
observed in other phage-biofilm studies [56]. Because of the high
bacterial mutation rate, bacteria can become resistant for phage
infection within a short period of time. In addition phage have a
lower coevolutionary potential than their bacterial hosts [57],
giving the bacterial resistant mutants the opportunity to grow thick
biofilms. Lacqua et al. [56] even found that after exposure of an E.
coli biofilm to two lytic phages (OP7061 and OP10081), each
emerging phage-resistant strain showed an increased clumping in
liquid media, biofilm formation and production of fimbria-like
extracellular structures compared to the wild type. This suggests
that growth as a biofilm might even be one of the mechanisms for
phage resistance. In addition, although persister cells (cells
characterized by a transient phase of slow growth or dormancy)
do not survive infections by lytic phages, they are only killed when
the persisters switch to normal growth and the lytic process is able
to proceed [58]. This phenomenon can delay the bacterial cell lysis
from minutes to hours and can hereby delay the phage-mediated
degradation of the biofilm community.
Phage-mediated biofilm degradation is brought about by
bacterial lysis on the one hand and EPS depolymerization on
the other hand, which probably act synergistically. The absence of
biofilm degradation caused by viral attached EPS depolymerases
alone, as observed here upon usage of UV inactivated phage
particles, does not rule out the essential contribution of these EPS
depolymerases in phage-mediated biofilm degradation. One can
hypothesize that phage need their viral EPS depolymerization
activity to tunnel through the biofilm to gain access to neighboring
host cells, without completely disrupting the biofilm as this would
also remove their potential new hosts. Complete absence of EPS
depolymerization activity would therefore reduce biofilm degra-
dation activity by phage as phage diffusion through the biofilm
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E79, which doesn’t have any EPS depolymerases and was more
successful at infecting surface cells than cells at depth in the biofilm
[59].
It is generally recognized that bacteria predominantly live in
biofilms. With regard to phage therapy, phages with viral-
attached EPS depolymerases should therefore preferably be
selected for, as they are after all able to break down biofilms by
attacking two of their main constituting parts, bacterial cells and
EPS material. However, one of the major hurdles with regard to
phage therapy still to overcome is their narrow host range,
conferred by the high specificity of their associated EPS
d e p o l y m e r a s e s[ 4 3 , 6 0 , 6 1 ] .T h i sr e s t r i c t st h ep h a g ei ni n f e c t i n g
only a very few strains of one single species. As observed in our
study, phage Q15 only infects seven P. putida strains out of a
selection of 53 but conferred also a marked difference in
breaking down PpG1 and RD5PR2 biofilms. Therefore, one
should first carefully identify the bacterial pathogens before
therapy with a highly lytic phage with a proper viral attached
E P Sd e p o l y m e r a s ec a nb es t a r t e d .T h ec h a n c eo ff i n d i n gs u c ha
specific phage is however likely to be low, and nonetheless
bacteria easily develop resistance to phages. From this point of
view, application of ‘phage cocktails’ directed at numerous
strains of the target species in combination with the concept of
‘engineering’ highly lytic phages with the appropriate EPS
degrading enzymes are powerful tools opening new perspectives
in phage therapy.
Supporting Information
Figure S1 Relative biofilm forming capacities of a
collection of 53 P. putida strains. The average biofilm
formation of each strain (Ax) is the result of eight independent
experiments with A0 being the uninoculated control sample. For
each strain, the average relative biofilm forming capacity ((Ax-A0)/
Average(An-A0)) and standard deviation is given.
(TIF)
Figure S2 Electron microscopic image of negatively
stained P. putida phage Q15 particles.
(TIF)
Figure S3 Microbiological characteristics of phage Q15.
(A) pH-stability. Phage counts (P) are validated after a 24 h
exposure at room temperature and given relative to a control
sample (P0). For each pH, the average and standard deviation of
three independent experiments is given. (B) Adsorption curves of
Q15 on its host PpG1 (light gray) and on the RD5PR2 strain (dark
gray). Values are given relative to phage number at time point
zero. In each case, the average and standard deviation of three
independent experiments is given. (C+D) One-step growth curves
of Q15 on PpG1 (C) and on RD5PR2 (D) showing the amount of
phage (P) released relative to the initial phage number (P0) at time
point zero. In each case, the average and standard deviation of
three independent experiments is given.
(TIF)
Figure S4 Genomic map of Q15 and gh-1. Genes, in the
three forward (left to right) reading frames, are represented by
filled grey boxes depending on the percentage of amino-acid
identity between Q15 and gh-1, while white boxes indicate unique
genes to one phage. The same gene numbering system, starting
from left to right in the genomic sequence, as that of T7 was used.
Genes which only have sequence similarity to the ‘T7-like virus’
gh-1 are simply named ‘gh-1/’ followed with the similar gene
number. Genes that are not present or have no sequence similarity
to a previously characterized T7-like phage are named ‘Q15/’ with
gene numbering also from left to right in the genome.
Experimentally confirmed structural proteins are marked with
an asterisk. The host and phage specific RNA polymerase
promoters are indicated by double and single arrowheads,
respectively, indicating the orientation of transcription. White
spheres above the map indicate r-independent terminators.
(TIF)
Figure S5 CLUSTALW alignment of the phage RNAP of
Q15, gh-1 and T7. Amino-acid sequences of phage RNAP that
are responsible for specific recognition and binding to the phage
promoter sequence (Q15: 737–769) and for making additional
contacts with the promoter sequence (Q15: 90–101) were aligned.
(TIF)
Table S1 Putative genes of Q15 and their homologies to
gh-1. The same gene numbering system, starting from left to
right in the genomic sequence, as that of T7 was used. Genes
which only have sequence similarity to gh-1 are simply named
‘gh-1/’ followed with the similar gene number. Genes that are not
present or have no sequence similarity to a previously
characterized T7-like phage are named ‘Q15/’w i t hg e n e
numbering from left to right in the genome. 44 of the 50
potential genes contain a AUG initiation codon, while GUG is
used for the remaining six ORFs. All three stop codons are used
in Q15, with UAA being the most frequent. The use of the second
codon GCU (alanine) in high expressed proteins (Gp2.5, Gp3,
Gp3.5, Gp8, Gp9, Gp10, Gp12, Gp15 and Gp17) as found
within T7, QYeO3-12 and QSG-JL2, is not completely conserved
within Q15. Gp8 and Gp10 with GCA and Gp15 with GCC, also
encode for alanine, while Gp9 and Gp12 have serine and proline
as second amino-acid, respectively.
(DOC)
Table S2 Structural proteome of phage Q15.
(DOC)
Table S3 Predicted promoter sequences in the genome
of Q15. The P. putida host promoter sequences are given and their
210 and 235 boxes are underlined as well as the transcription
start at +1. In the second part of the table, the Q15 promoter
sequences are aligned and a consensus sequence is presented. Also
an alignment of consensus promoter sequences of all classified ‘T7-
like viruses’ in the NCBI database is presented. Conserved
nucleotides, when compared with the Q15 consensus are marked
in grey.
(DOC)
Table S4 Predicted s-independent terminators in the
genome of Q15. Paired nucleotides in the stem-loop structure are
underlined.
(DOC)
Text S1 Genome organization and analysis of phage
Q15.
(DOC)
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